Molecular detection and typing of human papillomavirus in laryngeal carcinoma specimens

Acta Oto-Laryngologica

Volumn 125, Issue 8, 2005, Pages 888-893

  Torrente, Mariela C ^a,b   Ampuero, Sandra ^a   Abud, Maritza ^a   Ojeda, Jose M ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b NONE   (Chile)

Author keywords

Genotyping; Laryngeal cancer; Viral genome; Viral genotyping

Indexed keywords

BETA GLOBIN; VIRUS DNA;

ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CLINICAL ARTICLE; DNA DETERMINATION; GENETIC CONSERVATION; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LARYNGEAL BIOPSY; LARYNX CARCINOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA; VIRUS GENOME; WART VIRUS;

EID: 24044478747     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480510038220     Document Type: Article

References (23)

1. Million R, Cassisi N, Clark J. Cancer of the head and neck. In: De Vita VT, Hellman S, Rosemberg SA, editors. Cancer: principles and practice of oncology. Philadelphia, PA: J.B. Lippincott Co.; 1989. p. 488-590.
2. Ullman EV. On the aetiology of the laryngeal papilloma. Acta Otolaryngol (Stockh) 1923;5:317-34.
3. McKaig RG, Baric RS, Losan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998;20:250-65.
4. Munger K, Baldwin A, Edwards KM, Hayakawa H, Hguyen CL, Owens M, et al. Mechanisms for human papillomavirus-induced oncogenesis. J Virol 2004;78:11451-60.
5. Park NH, Kang MK. Genetic instability and oral cancer. Electron J Biotechnol 2000;3:31-65.
6. Gorgoulis VG, Zacharatos P, Kotsinas A, Kyroudi A, Rassidakis A, Ikonomopoulos J, et al. Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 1999;30:274-83.
7. Smith EM, Summersgill KF, Allen J, et al. Human papillomavirus and risk of laryngeal cancer. Ann Otol Rhinol Laryngol 2000;109:1069-86.
8. Azzimonti B, Hertel L, Aluffi P, et al. Demonstration of multiple HPV types in laryngeal premalignant lesions using polymerase chain reaction and immunohistochemistry. J Med Virol 1999;59:110-6.
9. Almadori G, Cadoni G, Cattani P, Galli J, Bussu F, Ferrandina G, et al. Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma. Clin Cancer Res 2001; 7:3988-93.
10. Atula S, Grenman R, Kujari H, Syrjänen S. Detection of human papillomavirus (HPV) in laryngeal carcinoma cell lines provides evidence for a heterogeneic cell population. Eur J Cancer 1999;35:825-32.
11. Venuti A, Manni V, Morello R, De Marco F, Marzetti F, Marcante ML. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol 2000;60:396-402.
12. Brandwein MS, Biller H, Nuovo GJ. Analysis of prevalence of human papilloma virus in laryngeal carcinomas. Ann Otol Rhinol Laryngol 1993;102:309-13.
13. Lie ES, Karlsen F, Holm R. Presence of human papilloma virus in squamous cell laryngeal carcinomas. A study of thirty-nine cases using polymerase chain reaction and in situ hybridization. Acta Otolaryngol (Stockh) 1996;116: 900-5.
14. Pérez-Ayala M, Ruiz-Cabello F, Esteban F, Concha A, Redendo M, Oliva MR, et al. Presence of HPV 16 sequences in laryngeal carcinomas. Int J Cancer 1990;46:8-11.
15. Manos M, Ting Y, Wright DK, Lewis AI, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cell 1989;7:209-14.
16. Chen S, Tabrizi SN, Fairley CK, Borg AJ, Garland SM. Simultaneous detection and typing strategy for human papillomavirus based on PCR and restriction endonuclease mapping. Biotechniques 1994;17:138-43.
17. Das BC, Sharma JK, Gopalakrisna V, Luthra UK. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 1992;73:2327-36.
18. Shafti-Kerarnat S, Hendisarya A, Kriebnber E, Meneguzzi G, Slopetzky K, Kirnbaner R. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol 2003;77:13125-35.
19. Karlsen F, Kalantari M, Chitemerere M, Johansson B, Hagmar B. Modification of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab Invest 1994;71: 604-11.
20. Kleter B, van Doorn LJ, Schegger J, Schrauwen L, van Krimpen K, Burger M, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998; 153:1731-9.
21. Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996;34:745-7.
22. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsague X, Shah K, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
23. Ferreccio C, Prado R, Luzorono A, Ampuero S, Snijders P, Meijer C, et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 2004; 13:2271-6.